Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

USP Science & ResearchUSP Science & Research
VS
AUROBINDO PHARMA LTDAUROBINDO PHARMA LTD
USP Science & Research

USP Science & Research

12601 Twinbrook Pkwy, 20852, Rockville, MD, US

Last Update: 04/05/2026

View Profile
843/1000Good

Scientific research and the expertise of our staff and volunteers are at the root of our work in advancing public health by ensuring the quality and safety of medicines, dietary supplements, and food ingredients. We are committed to rigorous science to help protect pati...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:0
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, 500032, IN

Last Update: 03/04/2026

View Profile
Between 750 and 799
https://www.aurobindo.com/
778/1000Fair

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, brand...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,862
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
USP Science & Research

USP Science & Research

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for USP Science & Research in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AUROBINDO PHARMA LTD in 2026.

Incidents

Incident History - USP Science & Research (X = Date, Y = Severity)

USP Science & Research cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - AUROBINDO PHARMA LTD (X = Date, Y = Severity)

AUROBINDO PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
USP Science & Research

USP Science & Research

Incidents
No explicit notable incidents reported.
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Incidents
No explicit notable incidents reported.

FAQ

Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one has the best AI Cybersecurity Score ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one has experienced more cyber incidents in the past ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one has experienced more cyber incidents this year ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one has experienced at least one ransomware attack ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one has experienced at least one data breach ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one has experienced at least one targeted cyberattack ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one has experienced at least one vulnerability ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one holds the most compliance certifications ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one holds the fewest compliance certifications ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one has the most subsidiaries ?
Between USP Science & Research company and AUROBINDO PHARMA LTD company, which one has the largest number of employees ?
Between USP Science & Research and AUROBINDO PHARMA LTD, which company holds both SOC 2 Type 1 certifications ?
Between USP Science & Research and AUROBINDO PHARMA LTD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - USP Science & Research or AUROBINDO PHARMA LTD ?
Which company is PCI DSS compliant - USP Science & Research or AUROBINDO PHARMA LTD ?
Between USP Science & Research and AUROBINDO PHARMA LTD, which company complies with HIPAA regulations for healthcare data ?
Between USP Science & Research and AUROBINDO PHARMA LTD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-8325
SUMMARY

A maliciously crafted PDF file, when parsed through Autodesk Revit, can force an Out-of-Bounds Write vulnerability. A malicious actor may leverage this vulnerability to cause a crash, cause data corruption, or execute arbitrary code in the context of the current process.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-7867
SUMMARY

A flaw was found in udisks2. A local attacker with an active console session can exploit insufficient authorization checking on the 'as-user' option in the org.freedesktop.UDisks2.Filesystem.Mount() D-Bus method. This allows the attacker to spoof the 'as-user' parameter, mounting filesystems on behalf of arbitrary users, including privileged accounts. This can lead to local privilege escalation through mount point injection and manipulation of the mount namespace visible to privileged users.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-7406
SUMMARY

A maliciously crafted BMP file, when parsed through certain Autodesk products, can force a Untrusted Pointer Dereference vulnerability. A malicious actor can leverage this vulnerability to execute arbitrary code in the context of the current process.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-7405
SUMMARY

A maliciously crafted TIF file, when parsed through certain Autodesk products during image import, can cause an Out-of-Bounds Read in the image handling library. A malicious actor can leverage this vulnerability to cause a denial of service

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 5.5)
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
1.8
CVE-2026-71555
SUMMARY

PILOS (Platform for Interactive Live-Online Seminars) is a frontend for BigBlueButton. From 2.1.0 until 4.14.1, PILOS does not send a Cross-Origin-Opener-Policy response header, so pages opened by PILOS via a link that opens a new browsing context (e.g., target="_blank") retain a window.opener reference back to the originating PILOS tab. A malicious destination page reached this way can use window.opener to navigate or manipulate the original PILOS tab, a technique known as reverse tabnabbing, potentially redirecting an authenticated user to a phishing page that mimics PILOS. This issue is fixed in version 4.14.1.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 4.1)
CVSS3
Base Score: 4.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.3